Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer von Hendrikse, Cynthia S E, Theelen, Pauline M M, Verhaegh, Wim, Lambrechts, Sandrina, Bekkers, Ruud L M, van de Stolpe, Anja, Piek, Jurgen M J

Volltext

Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low‐grade ovarian carcinoma von Hendrikse, Cynthia S. E., Ploeg, Phyllis, Kruis, Nienke M. A., Wilting, Jody H. C., Oosterkamp, Floor, Theelen, Pauline M. M., Lok, Christianne A. R., Hullu, Joanne A., Smedts, Huberdina P. M., Vos, M. Caroline, Pijlman, Brenda M., Kooreman, Loes F. S., Bulten, Johan, Lentjes‐Beer, Marjolein H. F. M., Bosch, Steven L., Stolpe, Anja, Lambrechts, Sandrina, Bekkers, Ruud L. M., Piek, Jurgen M. J.

Volltext

Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol von van der Ploeg, Phyllis, Hendrikse, Cynthia SE, Thijs, Anna MJ, Westgeest, Hans M., Smedts, Huberdina PM, Vos, M Caroline, Jalving, Mathilde, Lok, Christianne AR, Boere, Ingrid A., van Ham, Maaike APC, Ottevanger, Petronella B., Westermann, Anneke M., Mom, Constantijne H., Lalisang, Roy I., Lambrechts, Sandrina, Bekkers, Ruud LM, Piek, Jurgen MJ

Volltext